Erik J. Dasbach

Statistics

Publications

Citations

4.7K

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Michigan

Cancer Registry of Norway

Danish Cancer Society

Erik J. Dasbach is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacoeconomics, medicine, and cost-effectiveness analysis.

Publications per year

1991–2021

Publications

The Beaver Dam Health Outcomes study

Dennis G. Fryback, Erik J. Dasbach, Ronald Klein et al. · Medical Decision Making · 1993 · 737 citations

Pharmacy, Community Health, Population Health Sciences +17

Model for Assessing Human Papillomavirus Vaccination Strategies

Elamin H. Elbasha, Erik J. Dasbach, Ralph P. Insinga · Emerging infectious diseases · 2007 · 494 citations · Full text

Medicine, Pharmacoeconomics, Preventive Medicine +17

Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy

David W. Bates, L. Joseph Su, Donghui Yu et al. · Clinical Infectious Diseases · 2001 · 449 citations

Pharmacy, Nephrology, Pharmacoeconomics +12

Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 337 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Model of Complications of NIDDM: I. Model construction and assumptions

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 260 citations

Medicine, Biostatistics, Nephrology +17

1–5 of 44